Sign Up to like & get
recommendations!
0
Published in 2025 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2025.43.16_suppl.e22524
Abstract: e22524 Background: CHIP prevalence in cancer (CA) patients (pts) is estimated at 30%, its presence being associated to higher risk of therapy-related myeloid neoplasms (TRMN). We hypothesized CHIP may not only predispose to TRMN but…
read more here.
Keywords:
cancer;
clonal dynamics;
chip prevalence;
chip ... See more keywords